2003
DOI: 10.1007/978-1-4615-0061-2_19
|View full text |Cite
|
Sign up to set email alerts
|

Pharmaceutical Applications of In Vivo EPR

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2003
2003
2011
2011

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(14 citation statements)
references
References 88 publications
0
14
0
Order By: Relevance
“…34,107,108 Similarly the monitoring of the polymerization process in bone cement formation could be followed to provide direct information on the status of this complex therapeutic intervention. 109 It is likely that in vivo EPR could be of great practical use for both the development of implanted therapeutic systems and for monitoring the status of implants in individual patients.…”
Section: Characterization Of Drug Delivery Systemsmentioning
confidence: 99%
“…34,107,108 Similarly the monitoring of the polymerization process in bone cement formation could be followed to provide direct information on the status of this complex therapeutic intervention. 109 It is likely that in vivo EPR could be of great practical use for both the development of implanted therapeutic systems and for monitoring the status of implants in individual patients.…”
Section: Characterization Of Drug Delivery Systemsmentioning
confidence: 99%
“…Oxygen partial pressure is a very important parameter in most metabolic processes. Furthermore, certain drugs have different pharmacological effects depending on the local pO 2 and pH (6). Recent advances in ESR combined with new insights and information from cell and molecular biology mean that critical determinants for diagnosis and therapy can now be probed.…”
Section: Introductionmentioning
confidence: 99%
“…A pH-sensitive spin probe has been used with model systems for biological applications at low frequency. An extension of this work may find practical application in pharmaceutical studies, as pH is known to be a key parameter governing drug delivery [79] .…”
Section: Site-specific Agentsmentioning
confidence: 99%
“…The primary limitations to the clinical use of EPRI, sample heating and small penetration depths/small sample sizes are being overcome with rapid instrumental developments, such as low field resonators, three-dimensional EPRI techniques, and other techniques to introduce spectral and temporal components to the three-dimensional image [112,113] .…”
Section: Summary and Prospectsmentioning
confidence: 99%